WIHS


Also found in: Acronyms, Wikipedia.

WIHS

AIDS A clinical trial–Women's Interagency HIV Study
Mentioned in ?
References in periodicals archive ?
(31) Researchers working with the WIHS cohort, (27) US residents in 15 states or cities, (29) and the European-US-Australian DAD group (8) tracked nonsignificant drops in incidence, (27) an initial decline then stable incidence, (29) and no change in incidence (8) (Table 1).
The investigators used accepted statistical methods to compare lung cancer incidence (new diagnoses) in WIHS and MACS members with and without HIV infection.
"The relatively low use of hormonal contraception among WIHS participants limited the statistical power of our study, and therefore our ability to detect very small effects on treatment response," cautions Dr.
Starting highly active antiretroviral therapy for HIV infection: is it WIHS to wait?
In the WIHS study published this year, risk factors for condylomas identified among HIV-positive women were cytologic abnormalities, HPV, smoking, no HAART (highly active antiretroviral therapy), and a low CD4 count, Dr.
Prevalence and predictors of skin disease in the Women's Interagency HIV Study (WIHS).
For example, analysis of data from more than 8,000 participants in the Multicenter AIDS Cohort Study (MACS) and the Women's Interagency HIV Study (WIHS) demonstrated that participants who were HIV-seropositive were 1,100 times more likely to develop an AIDS-associated illness than those who were HIV-seronegative.
The initial findings of the Women's Interagency HIV Study (WIHS) reinforce what is known about the financial and psychosocial issues confronting many women living with HIV/AIDS -- including poverty, difficulties obtaining adequate housing and transportation, and both their own and their partners' substance abuse problems, for example.
In contrast to the Basile-Ryan and SRLVCU (1997) findings, that most of the people of color surveyed were unaware of viral loads and t-cell counts, most of the women in this study had had a t-cell count (94 percent) or viral load test (95 percent), and almost half of the sample were participants in the Women's Interagency HIV Study (WIHS).
In a 1984-2011 study of 2549 women in the Women's Interagency HIV Study (WIHS) and 4274 men in the Multicenter AIDS Cohort Study (MACS), all participants had a history of smoking.
The study involved HIV-positive and negative men in the Multicenter AIDS Cohort Study (MACS) and HIV-positive and negative women in the Women's Interagency HIV Study (WIHS) (Table 1).
In addition, two large based multi-center cohort studies of HIV-infected women conducted in the United States--the Women's Interagency HIV Study (WIHS) and the HIV Epidemiology Research Study (HERS) - have demonstrated a similar prevalence of CIN (17% and 18%) based on cytology, and a lower prevalence of high-grade squamous intraepithelial lesions and cancer: less than 3% in both cohorts.